Nailesh Bhatt Net Worth & Insider Trades
Nailesh Bhatt - Director, Sonnet Biotherapeutics Holdings, Inc
What is Nailesh Bhatt's Net Worth?
The current estimated net worth of Sonnet Biotherapeutics Holdings, Inc's Director, Nailesh Bhatt, is estimated to be about $4.42K . Nailesh Bhatt owns about 30,733 units of Sonnet Biotherapeutics Holdings, Inc common stock. In the last 3 years at Sonnet Biotherapeutics Holdings, Inc, Nailesh Bhatt has sold an estimated value of $0 worth.
What is Nailesh Bhatt's Past Insider Trading?
Nailesh Bhatt's largest purchase order was 25,000 units , worth over $5.8K on May 18, 2023. In total, Nailesh Bhatt has made about 5 transactions over 3 years of their time at Sonnet Biotherapeutics Holdings, Inc. Nailesh Bhatt usually trades in April, with the busiest year in 2020 and 2022.
Nailesh Bhatt
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Nailesh Bhatt's' Mailing Address?
- Mailing address is C/o Sonnet Biotherapeutics Holdings, Inc 100 Overlook Center Princeton NJ 08540 NJ
Sonnet Biotherapeutics Holdings, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Pankaj Mohan, Ph.D. | 2020 | $490,000 | $243,954 | $1,161,114 | - | - | $1,895,068 |
| Pankaj Mohan, Ph.D. | 2019 | $367,500 | $180,616 | - | - | - | $548,116 |
| John Cini, Ph.D. | 2020 | $290,000 | $98,740 | $283,917 | - | - | $672,657 |
| John Cini, Ph.D. | 2019 | $102,000 | $38,769 | - | - | - | $140,769 |
| Jay Cross | 2020 | $307,500 | $113,555 | $283,917 | - | - | $704,972 |
| Jay Cross | 2019 | $104,167 | $21,405 | - | - | - | $125,572 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1106838/000149315221012861/formdef14a.htm
What are Sonnet Biotherapeutics Holdings, Inc's Past Insider Trades?
Sonnet Biotherapeutics Holdings, Inc's most recent insider trade came on May 31, 2023 by Albert Dyrness who bought 23,255 units worth $10.88K . In the last 3 years, insiders at Sonnet Biotherapeutics Holdings, Inc have sold an estimated value of $47.11K and bought an estimated value of $242.31K worth of shares. Insider trading is most common in April, with the busiest year in 2022 and 2020. The most active traders at the company are Pankaj Mohan, Chairman, Albert Dyrness, Director, and John Cini, Chief Scientific Officer .
Sonnet BioTherapeutics Holdings, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||